Cook Medical launches Acrobat® 2 Calibrated Tip Wire Guide

Facebook
Google+
https://www.biospeakindiana.com/cook-medical-launches-acrobat-2-calibrated-tip-wire-guide">
Twitter
LINKEDIN

Bloomington, Ind. – Cook Medical’s Endoscopy business unit redefines access with the introduction of their latest wire guide, the next generation Acrobat® 2 Calibrated Tip Wire Guide. The Acrobat 2 provides the tip flexibility needed for ductal navigation.

“We’re very excited to launch the Acrobat 2 wire guide,” said Barry Slowey, president of Cook Medical’s Endoscopy division. “We’ve engineered the Acrobat 2 wire guide to give you the optimal combination of tip flexibility and pushability whether you are facing a routine ERCP or a complex procedure. The Acrobat 2 wire guide gives you the tool you need for reliable access to deliver therapy throughout the biliary and pancreatic ducts.”

Incorporating technology from Cook’s Interventional Radiology business unit to aid in traversing biliary and pancreatic ducts, the Acrobat 2 enables the creation of an alpha loop when navigating strictures, and has at least 35% greater tip flexibility than its major competitors.*

The Acrobat 2 calibrated platinum spring-coil tip is engineered for gentle contact with the tissue of the pancreaticobiliary anatomy and allows for flouroscopic visualization of the tip of the wire guide. The Acrobat 2 has a 5.8 cm hydrophilic coated tip that reduces friction, improving trackability and access of challenging anatomy.

Other important attributes of the Acrobat 2 include:

  • 29% greater pushability than the initial 0.035” version of the Acrobat wire guide.
  • 1:1 torqueability for precise rotation of the wire when needed for selective cannulation andnavigation of ducts.
  • The Mark V System® provides high-contrast visualization of movement and depth ofinsertion.The Acrobat 2 is available in both 0.025- and 0.035-inch diameters and 205 cm, 260 cm and 450 cm lengths, with both straight and angled tips. The Acrobat 2 can also be used during sphincterotomy.

For more information about the Acrobat 2 and other endoscopy products, visit cookmedical.com/endoscopy.

About Cook Medical

Since 1963 Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities. Find out more
at www.cookmedical.com, and for the latest news, follow us on Twitter, Facebook and LinkedIn.

*Benchtop test data on file at Cook Medical.

For more information about other endoscopy products, visit cookmedical.com/endoscopy. Dr. Mario Zaritzky is a paid consultant for Cook Medical.

Device information:

Humanitarian Device. Authorized by Federal law for use in the treatment of lengthening atretic esophageal ends and creating an anastomosis with a non-surgical procedure in pediatric patients, up to one year of age with esophageal atresia without a tracheoesophageal fistula (TEF), or in pediatric patients up to one year of age for whom a concurrent TEF has been closed as a result of a prior procedure. This device is indicated for atretic segments < 4cm apart. The effectiveness of this device for this use has not been demonstrated.

Data supporting the safety and probable benefit of the Flourish device include results from 16 patients who had the Flourish device placed. In the limited data provided, all of the infants had a successful joining of their esophagus, with no remaining gap, within three to 10 days after receiving the device. However, 13 of the 16 patients developed a complication that caused a narrowing in their esophagus (anastomotic stricture) that required a balloon dilation procedure, a stent or both to repair. Anastomotic strictures also occur from traditional surgery to repair the condition.

The Flourish device should not be used in patients older than one year, or who have teeth, which may damage the oral catheter. The device is also contraindicated in infants who have an existing tracheoesophageal fistula or who have esophageal segments that are more than 4 centimeters apart. This device should not be used for the creation of an anastomosis other than in the esophagus, patients without an established and appropriately sized gastrostomy tract, or patients having gastrostomy site signs of significant infection. Potential complications that may occur when the device is in place include ulceration or tissue irritation around the catheter implanted in the stomach and gum irritation due to pressure from the oral catheter.

Potential late complications following successful anastomosis include gastroesophageal reflux, tracheomalacia, esophageal dysmotility, recurrent asthma, and pulmonary infections.

About Cook Medical

Since 1963 Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities. Find out more at www.cookmedical.com, and for the latest news, follow us on Twitter, Facebook and LinkedIn.

Media Contact:
Marsha Lovejoy Global Manager, External Corporate Communications, Cook Medical
812.320.6903 (mobile)
812.339.2235, ext. 102750
marsha.lovejoy@cookmedical.com